HIV prevention — USMLE Step 3 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Use long-acting injectable cabotegravir with injection-visit HIV testing
The best answer is “Use long-acting injectable cabotegravir with injection-visit HIV testing”. Both oral tenofovir regimens require higher renal function than this patient has. Injectable cabotegravir does not require kidney monitoring and is the recommended PrEP option for serious kidney disease after HIV infection has been excluded. Oral tenofovir-containing PrEP requires renal thresholds; injectable cabotegravir is recommended instead for serious kidney disease with estimated creatinine clearance below 30 mL/min.
Reference: CDC HIV Nexus: Clinical Guidance for PrEP: https://www.cdc.gov/hivnexus/hcp/prep/index.html